Structure

Physi-Chem Properties

Molecular Weight:  446.25
Volume:  493.267
LogP:  6.883
LogD:  4.691
LogS:  -2.65
# Rotatable Bonds:  9
TPSA:  73.83
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.29
Synthetic Accessibility Score:  3.13
Fsp3:  0.31
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.936
MDCK Permeability:  1.8539820302976295e-05
Pgp-inhibitor:  0.594
Pgp-substrate:  0.707
Human Intestinal Absorption (HIA):  0.023
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.014
Plasma Protein Binding (PPB):  101.0121841430664%
Volume Distribution (VD):  2.906
Pgp-substrate:  0.316888689994812%

ADMET: Metabolism

CYP1A2-inhibitor:  0.959
CYP1A2-substrate:  0.452
CYP2C19-inhibitor:  0.94
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.614
CYP2C9-substrate:  0.984
CYP2D6-inhibitor:  0.983
CYP2D6-substrate:  0.943
CYP3A4-inhibitor:  0.673
CYP3A4-substrate:  0.119

ADMET: Excretion

Clearance (CL):  8.907
Half-life (T1/2):  0.757

ADMET: Toxicity

hERG Blockers:  0.408
Human Hepatotoxicity (H-HT):  0.801
Drug-inuced Liver Injury (DILI):  0.071
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.046
Maximum Recommended Daily Dose:  0.891
Skin Sensitization:  0.95
Carcinogencity:  0.036
Eye Corrosion:  0.003
Eye Irritation:  0.666
Respiratory Toxicity:  0.076

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC142308

Natural Product ID:  NPC142308
Common Name*:   Mulberrofuran W
IUPAC Name:   5-(6-hydroxy-1-benzofuran-2-yl)-4-[(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol
Synonyms:   Mulberrofuran W
Standard InCHIKey:  YUFBSQFJPYHMTK-QUYCRGELSA-N
Standard InCHI:  InChI=1S/C29H34O4/c1-19(2)7-5-8-20(3)9-6-10-21(4)11-14-25-26(16-24(31)17-27(25)32)29-15-22-12-13-23(30)18-28(22)33-29/h7,9,11-13,15-18,30-32H,5-6,8,10,14H2,1-4H3/b20-9-,21-11-
SMILES:  CC(=CCC/C(=CCC/C(=CCc1c(cc(cc1O)O)c1cc2ccc(cc2o1)O)/C)/C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL562810
PubChem CID:   45273151
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11429996]
NPO2578 Morus sp. Species Sulidae Eukaryota n.a. n.a. n.a. PMID[19072214]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2578 Morus sp. Species Sulidae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens CC50 = 70000.0 nM PMID[489140]
NPT211 Individual Protein Hypoxia-inducible factor 1 alpha Homo sapiens IC50 = 3620.0 nM PMID[489141]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 2700.0 nM PMID[489142]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Km = 3170000.0 nM PMID[489142]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Vmax = 5.49 microM/min PMID[489142]
NPT1120 Individual Protein Pancreatic triacylglycerol lipase Sus scrofa IC50 = 700.0 nM PMID[489143]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 = 70000.0 nM PMID[489140]
NPT27 Others Unspecified CC50 = 90000.0 nM PMID[489140]
NPT27 Others Unspecified Ratio = 1.3 n.a. PMID[489140]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens IC50 = 3050.0 nM PMID[489141]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 6070.0 nM PMID[489141]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC142308 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9931 High Similarity NPC23668
0.9931 High Similarity NPC193976
0.9864 High Similarity NPC297531
0.9864 High Similarity NPC213936
0.9863 High Similarity NPC207624
0.9796 High Similarity NPC235333
0.9795 High Similarity NPC106372
0.9795 High Similarity NPC115324
0.9795 High Similarity NPC58668
0.973 High Similarity NPC99199
0.973 High Similarity NPC148938
0.96 High Similarity NPC212967
0.96 High Similarity NPC164110
0.96 High Similarity NPC96342
0.96 High Similarity NPC268360
0.96 High Similarity NPC246647
0.9592 High Similarity NPC230713
0.9592 High Similarity NPC167576
0.9592 High Similarity NPC78335
0.9533 High Similarity NPC180924
0.9527 High Similarity NPC170169
0.9524 High Similarity NPC178202
0.9521 High Similarity NPC17816
0.9517 High Similarity NPC155144
0.94 High Similarity NPC72370
0.94 High Similarity NPC472462
0.9392 High Similarity NPC226644
0.9392 High Similarity NPC37226
0.9384 High Similarity NPC230943
0.9384 High Similarity NPC98926
0.9338 High Similarity NPC198490
0.9324 High Similarity NPC135325
0.932 High Similarity NPC210826
0.9315 High Similarity NPC302181
0.9295 High Similarity NPC53640
0.9276 High Similarity NPC137100
0.9272 High Similarity NPC1477
0.9272 High Similarity NPC183874
0.9272 High Similarity NPC213608
0.9257 High Similarity NPC12148
0.9257 High Similarity NPC130581
0.9247 High Similarity NPC53192
0.9231 High Similarity NPC39306
0.9205 High Similarity NPC67654
0.9205 High Similarity NPC5871
0.92 High Similarity NPC13282
0.9189 High Similarity NPC51641
0.9189 High Similarity NPC300267
0.9184 High Similarity NPC225884
0.9178 High Similarity NPC49108
0.9167 High Similarity NPC133065
0.915 High Similarity NPC247677
0.915 High Similarity NPC160015
0.9139 High Similarity NPC156244
0.9133 High Similarity NPC10027
0.9133 High Similarity NPC39929
0.9133 High Similarity NPC37208
0.9133 High Similarity NPC221868
0.9133 High Similarity NPC296030
0.9133 High Similarity NPC65775
0.9108 High Similarity NPC474591
0.9103 High Similarity NPC312056
0.9103 High Similarity NPC84515
0.9103 High Similarity NPC477239
0.9103 High Similarity NPC3448
0.9091 High Similarity NPC65504
0.9091 High Similarity NPC296957
0.9091 High Similarity NPC260902
0.9073 High Similarity NPC227122
0.9067 High Similarity NPC272194
0.9045 High Similarity NPC159508
0.9038 High Similarity NPC188486
0.9032 High Similarity NPC476349
0.9032 High Similarity NPC244750
0.9032 High Similarity NPC476350
0.9032 High Similarity NPC40583
0.9032 High Similarity NPC472877
0.9026 High Similarity NPC45131
0.9013 High Similarity NPC258249
0.9007 High Similarity NPC223988
0.9 High Similarity NPC77903
0.9 High Similarity NPC17101
0.8994 High Similarity NPC253730
0.8994 High Similarity NPC286230
0.8993 High Similarity NPC29577
0.8987 High Similarity NPC169471
0.8986 High Similarity NPC310340
0.8981 High Similarity NPC272722
0.898 High Similarity NPC275734
0.8974 High Similarity NPC260296
0.8974 High Similarity NPC304839
0.8974 High Similarity NPC220582
0.8974 High Similarity NPC115432
0.8954 High Similarity NPC125300
0.8954 High Similarity NPC253872
0.8954 High Similarity NPC474843
0.8954 High Similarity NPC263676
0.8954 High Similarity NPC41326
0.8947 High Similarity NPC295036
0.8947 High Similarity NPC470107
0.894 High Similarity NPC186397
0.894 High Similarity NPC37135
0.894 High Similarity NPC216624
0.8933 High Similarity NPC237208
0.8933 High Similarity NPC299011
0.8931 High Similarity NPC277480
0.8917 High Similarity NPC45124
0.8917 High Similarity NPC74854
0.8917 High Similarity NPC96031
0.8917 High Similarity NPC30655
0.891 High Similarity NPC196879
0.891 High Similarity NPC16935
0.8903 High Similarity NPC472461
0.8896 High Similarity NPC178964
0.8896 High Similarity NPC210942
0.8896 High Similarity NPC95842
0.8896 High Similarity NPC169990
0.8896 High Similarity NPC122365
0.8896 High Similarity NPC280530
0.8889 High Similarity NPC116604
0.8882 High Similarity NPC158338
0.8882 High Similarity NPC288036
0.8882 High Similarity NPC97028
0.8882 High Similarity NPC6923
0.8882 High Similarity NPC266499
0.8882 High Similarity NPC317492
0.8882 High Similarity NPC65589
0.8882 High Similarity NPC97029
0.8882 High Similarity NPC100985
0.8875 High Similarity NPC50394
0.8875 High Similarity NPC247973
0.8874 High Similarity NPC259632
0.8874 High Similarity NPC150215
0.8868 High Similarity NPC45449
0.8868 High Similarity NPC291110
0.8868 High Similarity NPC36320
0.8868 High Similarity NPC37183
0.8867 High Similarity NPC134621
0.8867 High Similarity NPC184649
0.8867 High Similarity NPC303185
0.8867 High Similarity NPC311144
0.8861 High Similarity NPC193998
0.8859 High Similarity NPC159855
0.8859 High Similarity NPC96791
0.8859 High Similarity NPC470636
0.8859 High Similarity NPC226942
0.8859 High Similarity NPC169479
0.8844 High Similarity NPC112757
0.8844 High Similarity NPC472368
0.8844 High Similarity NPC124269
0.8836 High Similarity NPC476333
0.8836 High Similarity NPC472367
0.8836 High Similarity NPC473391
0.8836 High Similarity NPC472364
0.8834 High Similarity NPC227906
0.8831 High Similarity NPC40356
0.8831 High Similarity NPC154683
0.8824 High Similarity NPC307780
0.8824 High Similarity NPC309979
0.8824 High Similarity NPC60413
0.882 High Similarity NPC247136
0.8816 High Similarity NPC106328
0.8816 High Similarity NPC172329
0.8816 High Similarity NPC145467
0.8816 High Similarity NPC39195
0.8816 High Similarity NPC2569
0.8816 High Similarity NPC27221
0.8816 High Similarity NPC168085
0.8816 High Similarity NPC256672
0.8816 High Similarity NPC35150
0.8816 High Similarity NPC7025
0.8808 High Similarity NPC196114
0.8808 High Similarity NPC99454
0.8808 High Similarity NPC130176
0.8805 High Similarity NPC263092
0.8805 High Similarity NPC155640
0.8805 High Similarity NPC1755
0.8805 High Similarity NPC1706
0.8805 High Similarity NPC59295
0.8805 High Similarity NPC39305
0.88 High Similarity NPC113770
0.88 High Similarity NPC251182
0.88 High Similarity NPC95123
0.88 High Similarity NPC66404
0.88 High Similarity NPC172182
0.88 High Similarity NPC262935
0.8797 High Similarity NPC304387
0.8792 High Similarity NPC250755
0.8792 High Similarity NPC96692
0.8792 High Similarity NPC103752
0.8792 High Similarity NPC18714
0.8792 High Similarity NPC105648
0.8784 High Similarity NPC472366
0.8782 High Similarity NPC13879
0.8782 High Similarity NPC472907
0.8776 High Similarity NPC188879
0.8776 High Similarity NPC228661
0.8776 High Similarity NPC62735
0.8774 High Similarity NPC89474
0.8774 High Similarity NPC303950

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC142308 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8968 High Similarity NPD3749 Approved
0.8776 High Similarity NPD2344 Approved
0.8654 High Similarity NPD7819 Suspended
0.8618 High Similarity NPD4378 Clinical (unspecified phase)
0.8544 High Similarity NPD3882 Suspended
0.8543 High Similarity NPD2309 Approved
0.8497 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8493 Intermediate Similarity NPD1240 Approved
0.8467 Intermediate Similarity NPD1549 Phase 2
0.8447 Intermediate Similarity NPD6959 Discontinued
0.8431 Intermediate Similarity NPD1511 Approved
0.8418 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8418 Intermediate Similarity NPD2801 Approved
0.8411 Intermediate Similarity NPD2800 Approved
0.84 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD1510 Phase 2
0.8378 Intermediate Similarity NPD1607 Approved
0.8377 Intermediate Similarity NPD2532 Approved
0.8377 Intermediate Similarity NPD2533 Approved
0.8377 Intermediate Similarity NPD2534 Approved
0.8365 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8355 Intermediate Similarity NPD3750 Approved
0.8354 Intermediate Similarity NPD7473 Discontinued
0.8354 Intermediate Similarity NPD1934 Approved
0.8344 Intermediate Similarity NPD3926 Phase 2
0.8344 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD2796 Approved
0.8323 Intermediate Similarity NPD1512 Approved
0.8289 Intermediate Similarity NPD1243 Approved
0.8282 Intermediate Similarity NPD6232 Discontinued
0.8269 Intermediate Similarity NPD920 Approved
0.8214 Intermediate Similarity NPD6559 Discontinued
0.8199 Intermediate Similarity NPD7768 Phase 2
0.8193 Intermediate Similarity NPD3818 Discontinued
0.8176 Intermediate Similarity NPD7411 Suspended
0.816 Intermediate Similarity NPD5494 Approved
0.8148 Intermediate Similarity NPD7075 Discontinued
0.8141 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8113 Intermediate Similarity NPD4380 Phase 2
0.8077 Intermediate Similarity NPD6799 Approved
0.8075 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6166 Phase 2
0.805 Intermediate Similarity NPD3226 Approved
0.8037 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD3748 Approved
0.8013 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD1247 Approved
0.7975 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7974 Intermediate Similarity NPD2935 Discontinued
0.7974 Intermediate Similarity NPD6100 Approved
0.7974 Intermediate Similarity NPD6099 Approved
0.7963 Intermediate Similarity NPD1465 Phase 2
0.7962 Intermediate Similarity NPD7390 Discontinued
0.7929 Intermediate Similarity NPD5844 Phase 1
0.7922 Intermediate Similarity NPD1471 Phase 3
0.7922 Intermediate Similarity NPD2346 Discontinued
0.7914 Intermediate Similarity NPD3817 Phase 2
0.7914 Intermediate Similarity NPD2296 Approved
0.7908 Intermediate Similarity NPD2799 Discontinued
0.7886 Intermediate Similarity NPD4287 Approved
0.7882 Intermediate Similarity NPD7074 Phase 3
0.7881 Intermediate Similarity NPD943 Approved
0.7879 Intermediate Similarity NPD919 Approved
0.7867 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD1551 Phase 2
0.7844 Intermediate Similarity NPD7229 Phase 3
0.7824 Intermediate Similarity NPD7054 Approved
0.7821 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6801 Discontinued
0.7778 Intermediate Similarity NPD7472 Approved
0.7748 Intermediate Similarity NPD3764 Approved
0.7738 Intermediate Similarity NPD5711 Approved
0.7738 Intermediate Similarity NPD5710 Approved
0.7719 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7286 Phase 2
0.7697 Intermediate Similarity NPD5402 Approved
0.7692 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7251 Discontinued
0.7677 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD6651 Approved
0.7658 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD1203 Approved
0.7644 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD7808 Phase 3
0.7632 Intermediate Similarity NPD2313 Discontinued
0.763 Intermediate Similarity NPD6797 Phase 2
0.763 Intermediate Similarity NPD5953 Discontinued
0.7593 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD6280 Approved
0.7576 Intermediate Similarity NPD6279 Approved
0.7566 Intermediate Similarity NPD4625 Phase 3
0.7558 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD4628 Phase 3
0.7543 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD1470 Approved
0.753 Intermediate Similarity NPD5761 Phase 2
0.753 Intermediate Similarity NPD5760 Phase 2
0.7529 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5406 Approved
0.7516 Intermediate Similarity NPD5408 Approved
0.7516 Intermediate Similarity NPD5404 Approved
0.7516 Intermediate Similarity NPD5405 Approved
0.75 Intermediate Similarity NPD6832 Phase 2
0.75 Intermediate Similarity NPD4908 Phase 1
0.7486 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD5403 Approved
0.7484 Intermediate Similarity NPD447 Suspended
0.7483 Intermediate Similarity NPD2798 Approved
0.7472 Intermediate Similarity NPD8434 Phase 2
0.7471 Intermediate Similarity NPD7199 Phase 2
0.7469 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD3751 Discontinued
0.745 Intermediate Similarity NPD9717 Approved
0.745 Intermediate Similarity NPD1608 Approved
0.7427 Intermediate Similarity NPD6808 Phase 2
0.7405 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD3268 Approved
0.7401 Intermediate Similarity NPD8313 Approved
0.7401 Intermediate Similarity NPD8312 Approved
0.7394 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD1201 Approved
0.7381 Intermediate Similarity NPD4288 Approved
0.7375 Intermediate Similarity NPD2654 Approved
0.7372 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD230 Phase 1
0.7362 Intermediate Similarity NPD5401 Approved
0.7326 Intermediate Similarity NPD3787 Discontinued
0.7303 Intermediate Similarity NPD2797 Approved
0.7301 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD411 Approved
0.7273 Intermediate Similarity NPD1729 Discontinued
0.7273 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1610 Phase 2
0.7267 Intermediate Similarity NPD422 Phase 1
0.7262 Intermediate Similarity NPD37 Approved
0.7251 Intermediate Similarity NPD6234 Discontinued
0.7248 Intermediate Similarity NPD17 Approved
0.7241 Intermediate Similarity NPD2403 Approved
0.7237 Intermediate Similarity NPD1876 Approved
0.7235 Intermediate Similarity NPD4967 Phase 2
0.7235 Intermediate Similarity NPD4965 Approved
0.7235 Intermediate Similarity NPD4966 Approved
0.7233 Intermediate Similarity NPD7033 Discontinued
0.7233 Intermediate Similarity NPD4308 Phase 3
0.7222 Intermediate Similarity NPD7003 Approved
0.7219 Intermediate Similarity NPD3972 Approved
0.7211 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD4361 Phase 2
0.7188 Intermediate Similarity NPD8151 Discontinued
0.7171 Intermediate Similarity NPD4749 Approved
0.716 Intermediate Similarity NPD6844 Discontinued
0.7159 Intermediate Similarity NPD7177 Discontinued
0.7143 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD4360 Phase 2
0.7135 Intermediate Similarity NPD4363 Phase 3
0.7127 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD3269 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD1548 Phase 1
0.7108 Intermediate Similarity NPD6273 Approved
0.7101 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD2861 Phase 2
0.7093 Intermediate Similarity NPD6971 Discontinued
0.7089 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1613 Approved
0.7078 Intermediate Similarity NPD3267 Approved
0.7078 Intermediate Similarity NPD1164 Approved
0.7078 Intermediate Similarity NPD3266 Approved
0.7076 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD7870 Phase 2
0.7068 Intermediate Similarity NPD7871 Phase 2
0.7067 Intermediate Similarity NPD1651 Approved
0.7062 Intermediate Similarity NPD7228 Approved
0.7059 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6355 Discontinued
0.7039 Intermediate Similarity NPD1252 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6780 Approved
0.7037 Intermediate Similarity NPD6777 Approved
0.7037 Intermediate Similarity NPD6779 Approved
0.7037 Intermediate Similarity NPD6781 Approved
0.7037 Intermediate Similarity NPD6778 Approved
0.7037 Intermediate Similarity NPD6782 Approved
0.7037 Intermediate Similarity NPD6776 Approved
0.7026 Intermediate Similarity NPD7783 Phase 2
0.7026 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7697 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data